{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:13:59Z","timestamp":1789442039005,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.clinthera.2009.04.010","type":"journal-article","created":{"date-parts":[[2009,5,14]],"date-time":"2009-05-14T09:11:21Z","timestamp":1242292281000},"page":"764-776","source":"Crossref","is-referenced-by-count":75,"title":["Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: Two single-dose, open-label, randomized-sequence, crossover studies"],"prefix":"10.1016","volume":"31","author":[{"given":"Daphne D.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine K.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary B.","family":"Wire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Wook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva G.","family":"Kapsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian M.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2009.04.010_bib1","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa073275","article-title":"Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura","volume":"357","author":"Bussel","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2009.04.010_bib2","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2009.04.010_bib3","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/00043426-200308000-00017","article-title":"Intracranial hemorrhage in immune thrombocytopenic purpura: A retrospective analysis","volume":"25","author":"Butros","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.clinthera.2009.04.010_bib4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/asheducation-2001.1.282","article-title":"Platelets: An update on diagnosis and management of thrombocy-topenic disorders","volume":"1","author":"McCrae","year":"2001","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.clinthera.2009.04.010_bib5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jcrc.2005.09.008","article-title":"Thrombocy-topenia in medical-surgical critically ill patients: Prevalence, incidence, and risk factors","volume":"20","author":"Crowther","year":"2005","journal-title":"J Crit Care"},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2009.04.010_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0037-1963(00)90046-5","article-title":"Clinical issues and treatment advances in thrombocytopenia: Introduction","volume":"37","author":"Ozer","year":"2000","journal-title":"Semin Hematol"},{"key":"10.1016\/j.clinthera.2009.04.010_bib7","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1365-2141.2005.05542.x","article-title":"Hepatitis C virus-related thrombocytopenia: Clinical and laboratory characteristics compared with chronic immune thrombocy-topenic purpura","volume":"129","author":"Rajan","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clinthera.2009.04.010_bib8","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1182\/blood.V100.10.3457","article-title":"Recombinant human thrombopoie-tin: Basic biology and evaluation of clinical studies","volume":"100","author":"Kuter","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2009.04.010_bib9","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1038\/sj.onc.1205323","article-title":"The molecular and cellular biology of thrombopoietin: The primary regulator of platelet production","volume":"21","author":"Kaushansky","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.clinthera.2009.04.010_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0014-5793(95)01072-M","article-title":"Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, JAK2, and STAT3, and enhances agonists-induced aggregation in platelets in vitro","volume":"374","author":"Ezumi","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clinthera.2009.04.010_bib11","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1182\/blood.V94.4.1273","article-title":"Thrombopoietin-induced activation of the mitogen-activated protein ki-nase (MAPK) pathway in normal megakaryocytes: Role in endomitosis","volume":"94","author":"Rojnuckarin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2009.04.010_bib12","doi-asserted-by":"crossref","first-page":"13480","DOI":"10.1074\/jbc.274.19.13480","article-title":"Thrombopoietin signal transduction requires functional JAK2, not TYK2","volume":"274","author":"Drachman","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinthera.2009.04.010_bib13","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1182\/blood-2006-11-057968","article-title":"Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoie- tin receptor agonist","volume":"109","author":"Jenkins","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2009.04.010_bib14","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1056\/NEJMoa073255","article-title":"Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C","volume":"357","author":"McHutchison","year":"2007","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2009.04.010_bib15","first-page":"143","article-title":"Eltrombopag raises platelet count and reduces bleeding compared with placebo during short-term treatment in chronic idiopathic thrombocytopenic purpura: A phase III study","volume":"92","author":"Bussel","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.clinthera.2009.04.010_bib16","series-title":"Adopted by the 18th World Medical Assembly, Helsinki 1964 as amended by the 48th World Medical Assembly","year":"1996"},{"key":"10.1016\/j.clinthera.2009.04.010_bib17","series-title":"Guidance for industry food-effect bio-availability and fed bioequivalence studies","year":"2002"},{"key":"10.1016\/j.clinthera.2009.04.010_bib18","series-title":"Guidance for industry, bioanalytical method validation","year":"2001"},{"key":"10.1016\/j.clinthera.2009.04.010_bib19","series-title":"WinNonlin Professional User's Guide","year":"2003"},{"key":"10.1016\/j.clinthera.2009.04.010_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2165\/00003088-199937030-00003","article-title":"Effects of food on clinical pharmacokinetics","volume":"37","author":"Singh","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2009.04.010_bib21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF01068419","article-title":"A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bio-availability","volume":"15","author":"Schuirmann","year":"1987","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1016\/j.clinthera.2009.04.010_bib22","series-title":"Nonparametric Statistical Methods","author":"Hollander","year":"1973"},{"key":"10.1016\/j.clinthera.2009.04.010_bib23","series-title":"Design and Analysis of Bioavailability and Bioequivalence Studies","author":"Chow","year":"2000"},{"key":"10.1016\/j.clinthera.2009.04.010_bib24","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/clpt.1991.174","article-title":"Interference of dairy products with the absorption of ciprofloxacin","volume":"50","author":"Neunovonen","year":"1991","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2009.04.010_bib25","series-title":"Promacta (eltrombopag tablets). FDA oncologic drug advisory committee briefing document","year":"2008"},{"key":"10.1016\/j.clinthera.2009.04.010_bib26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10947-007-0107-8","article-title":"Zinc(II) complex of the edta bis(tyrosine) chelating agent","volume":"48","author":"Fisher","year":"2007","journal-title":"J Struct Chem"},{"key":"10.1016\/j.clinthera.2009.04.010_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0003-2670(01)82823-3","article-title":"Fluorescence reactions of eriochrome red B with metals Part 1: Detection of Be, Mg, Al, In, Ga and Zn+","volume":"73","author":"Perez Conde","year":"1974","journal-title":"Analytica Chimica Acta"},{"key":"10.1016\/j.clinthera.2009.04.010_bib28","series-title":"Prescribing Information. Promacta\u2122 (eltrombopag) tablets","year":"2008"},{"key":"10.1016\/j.clinthera.2009.04.010_bib29","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/j.1552-4604.1989.tb03260.x","article-title":"Ciprofloxacin pharmacokinetics after a standard or high-fat\/high-calcium breakfast","volume":"29","author":"Frost","year":"1989","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2009.04.010_bib30","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/j.1552-4604.1993.tb03926.x","article-title":"Effect of milk on absorption of norfloxacin in healthy volunteers","volume":"33","author":"Minami","year":"1993","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2009.04.010_bib31","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2165\/00003495-199957060-00003","article-title":"Antacids revisited: A review of their clinical pharmacology and recommended therapeutic use","volume":"57","author":"Maton","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2009.04.010_bib32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s002280050364","article-title":"Adverse events and discomfort in studies on healthy subjects: The volunteer's perspective. A survey conducted by the German Association for Applied Human Pharmacology","volume":"53","author":"Hermann","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2009.04.010_bib33","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJM199210153271601","article-title":"Withdrawal syndrome after the double-blind cessation of caffeine consumption","volume":"327","author":"Silverman","year":"1992","journal-title":"N Engl J Med"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809001192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809001192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T04:40:30Z","timestamp":1589776830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291809001192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0149291809001192"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.04.010","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}